
Organic Process Research and Development p. 336 - 345 (2017)
Update date:2022-07-31
Topics:
Goundry, William R. F.
Boardman, Kay
Cunningham, Oliver
Evans, Matthew
Jones, Martin F.
Millard, Kirsty
Rozada-Sanchez, Raquel
Sawyer, Yvonne
Siedlecki, Paul
Whitlock, Brian
Recently, the aminoquinazoline motif has been highly prevalent in anticancer pharmaceutical compounds. Synthetic methods are required to make this structure on a multikilo scale and in high purity. The initial route to aminoquinazoline AZD8931 suffered from the formation of late-stage impurities. To avoid these impurities, a new high-yielding Dimroth rearrangement approach to the aminoquinazoline core of AZD8931 was developed. Assessment of route options on a gram scale demonstrated that the Dimroth rearrangement is a viable approach. The processes were then evolved for large-scale production with learning from a kilo campaign and two plant-scale manufactures. Identification of key process impurities offers an insight into the mechanisms of the Dimroth rearrangement as well as the hydrogenation of a key intermediate. The final processes were operated on a 30 kg scale delivering the target AZD8931 in 41% overall yield.
Shandong Hongxiang Zinc Co., Ltd
Contact:086-0311-66187879
Address:DaWang developing zone
Qingzhou Baibang import and export co.,Ltd
Contact:+86-536-3265899
Address:No.338, Tuoshan Road
Contact:+86 021-51698675
Address:1701, Jielong Plaza, No.618 Pingliang Rd, ShangHai,China
Xi'an caijing Opto-Electrical Science & Technology Co., LTD
Contact:+86-29-88294447
Address:NO.168 Zhangba Rd. East, Xi'an, P.R.China
Liao Cheng All Win Chemicals Co.,LTD
Contact:86+0635-2991582
Address:Room 402,Unit 1,No.27 building.Zhong tong shi dai haoyuan,liaocheng city,Shan dong Province.China
Doi:10.1021/ja00191a036
(1989)Doi:10.1016/j.carres.2009.08.028
(2009)Doi:10.1016/j.jfluchem.2005.02.020
(2005)Doi:10.1002/anie.200903558
(2009)Doi:10.1021/acsmedchemlett.7b00296
(2017)Doi:10.1246/cl.1988.1639
(1988)